| Dr Maddur N Badarinath, MD | |
|
363 Fremont St Ste 100, Battle Creek, MI 49017-3395 | |
| (269) 969-6100 | |
| (269) 696-6102 |
| Full Name | Dr Maddur N Badarinath |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 48 Years |
| Location | 363 Fremont St Ste 100, Battle Creek, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255339222 | NPI | - | NPPES |
| 2792592 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 053737 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Battle Creek Hospital | 0547173478 | 157 |
News Archive
According to a new study all a healthy heterosexual woman needs to give their hormone levels a kick start is the smell of a man's sweat.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
The rate at which antidepressant drugs are prescribed for the nation's children and adolescents increased more than three fold between the early 1990s and 2001, according to a review of medical office survey data completed recently by researchers at Washington State University.
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.
› Verified 4 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
According to a new study all a healthy heterosexual woman needs to give their hormone levels a kick start is the smell of a man's sweat.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
The rate at which antidepressant drugs are prescribed for the nation's children and adolescents increased more than three fold between the early 1990s and 2001, according to a review of medical office survey data completed recently by researchers at Washington State University.
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.
› Verified 4 days ago
| Entity Name | Critical Care Pulmonary Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679520712 PECOS PAC ID: 2365439775 Enrollment ID: O20040428000426 |
News Archive
According to a new study all a healthy heterosexual woman needs to give their hormone levels a kick start is the smell of a man's sweat.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
The rate at which antidepressant drugs are prescribed for the nation's children and adolescents increased more than three fold between the early 1990s and 2001, according to a review of medical office survey data completed recently by researchers at Washington State University.
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.
› Verified 4 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
According to a new study all a healthy heterosexual woman needs to give their hormone levels a kick start is the smell of a man's sweat.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
The rate at which antidepressant drugs are prescribed for the nation's children and adolescents increased more than three fold between the early 1990s and 2001, according to a review of medical office survey data completed recently by researchers at Washington State University.
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maddur N Badarinath, MD 363 Fremont St Ste 100, Battle Creek, MI 49017-3395 Ph: (269) 969-6100 | Dr Maddur N Badarinath, MD 363 Fremont St Ste 100, Battle Creek, MI 49017-3395 Ph: (269) 969-6100 |
News Archive
According to a new study all a healthy heterosexual woman needs to give their hormone levels a kick start is the smell of a man's sweat.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
The rate at which antidepressant drugs are prescribed for the nation's children and adolescents increased more than three fold between the early 1990s and 2001, according to a review of medical office survey data completed recently by researchers at Washington State University.
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.
› Verified 4 days ago
Dr. Ireneo Yap Diaz Jr., M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49015 Phone: 269-966-5600 Fax: 269-660-6041 | |
Dr. Thomas F. Ignaczak, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 363 Fremont St Ste 203, Battle Creek, MI 49017 Phone: 269-969-6123 Fax: 269-969-6122 | |
Samir Bateriwala, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49037 Phone: 269-966-5600 | |
Donald H. Batts, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 363 Fremont St, Suite 305, Battle Creek, MI 49017 Phone: 269-245-8302 Fax: 269-245-8309 | |
Eric John Smith, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St Ste 100, Battle Creek, MI 49017 Phone: 269-245-5100 | |
Mrs. Ashley Marie Fugate, FNP-BC Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 181 Emmett St W, Battle Creek, MI 49037 Phone: 269-965-8866 | |
Shekhar C Thakur, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 231 North Ave, Battle Creek, MI 49017 Phone: 269-565-1111 Fax: 269-565-1900 |